Featured Content
Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection
A ctDNA testing method has the capability to predict cancer recurrence, which could help guide therapy selections and uncover new drug development opportunities.
Synthetic or Plant-Based Cannabis for Symptom Relief in Patients With Cancer: Do We Have Any Evidence?
In clinical practice, most physicians and nurse practitioners do not feel comfortable enough with their medical knowledge of cannabis to offer it to patients.
Fall of Star Cancer Researcher Brings Broader Picture Into View
Dr José Baselga failed to disclose his financial ties to pharmaceutical companies in top-tier journals, causing many to question whether conflicts of interest are being ...
Talazoparib Found to Confer a Survival Advantage in BRCA1/2-Positive Breast Cancer
Oral treatment with talazoparib improved progression-free survival and some quality of life measures compared with standard chemotherapy.
BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
Double mutants may predict resistance to PARP inhibitors and could also indicate sensitivity to alternative treatments.More Features>>>
Video Series
-
The Phase 3 PlanB Trial
-
Continue to Work?
-
Drug Resistance to CDK4/6 Inhibitors
-
Comparing Ribociclib and Palbociclib
-
Ribociclib, Abemaciclib, and Palbociclib
-
The Potential of CDK4/6 Inhibitors
-
How Cyclin D Plays A Role
-
Role of Cell Cycle in Progression
-
2016 SABCS: Clinical Insights
-
2016 SABCS: Clinical Insights
-
HER2-positive Metastatic and TNBC
-
Frontline Treatments
-
Treatment-related Neuropathy
-
ER-positive, HER2-negative
-
Emerging Medicines
-
Triple-negative Breast Cancer
-
Insights from the Lab and Clinic
-
Trastuzumab Resistance
-
Biologic Role of HER2
-
Strategies in Management
-
Lapatinib-based Regimen
-
Overcoming Trastuzumab Resistance
-
New Anti-HER2 Agents
-
HER2-targeted Therapies
-
Lapatinib and the Neoadjuvant Tx
-
Predicting Response/Resistance
-
AC-THP vs. TCHP Treatment
Breast Cancer News
Chemotherapy Plays a Role in Skeletal Muscle Atrophy in Patients With Breast Cancer
October 12, 2018
Breast Cancer Resources
More Breast Cancer Information
Plastics and Cancer
October 19, 2018
Few studies have evaluated the general exposure to plastics and cancer risk, and data on cancer risk among workers in the plastic industry are inconclusive.
A Vegan Diet and Cancer
October 12, 2018
There are no data on whether a vegan diet is an effective means of cancer prevention among high-risk populations.
Tissue Biopsy: What to Expect
October 05, 2018
This fact sheet informs patients about what to expect prior to, during, and after a tissue biopsy.
Sexual Health and Cancer Treatment
September 28, 2018
This fact sheet about sexual health provides patients with an overview of the way in which cancer treatment can affect sexual health and management options.
Finding Clinical Trials in Cancer
September 21, 2018
This fact sheet describes patient-directed strategies for finding clinical trials.
The Treatment Landscape of Breast Cancer
The treatment landscape in breast cancer has evolved dramatically within the past several decades.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Prostate Cancer | Regimens | Drugs |
| Rare Cancers | Regimens | |
| Renal Cell Carcinoma | Regimens | Drugs |
| Skin Cancer | Regimens | Drugs |
| Urologic Cancers | Regimens | Drugs |
Cancer Therapy Advisor Articles
- Are Next-Gen Antibody-Drug Conjugates a Path Forward for Non-Hodgkin Lymphoma and Myeloma?
- Ponatinib Tops Bosutinib for Third-Line Treatment of CML in a Comparative Analysis
- Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection
- Apalutamide Does Not Diminish Quality of Life in Nonmetastatic Castration-Resistant Prostate Cancer
- Treatment Delays May Mean Worse Survival in Head and Neck Cancer
- FDA-Approved Breast Cancer Drug Treatments
- A Trained Dog Smells Early-Stage Lung Cancer With a High Degree of Accuracy
- FDA-Approved Colorectal Cancer Drug Treatments
- Synthetic or Plant-Based Cannabis for Symptom Relief in Patients With Cancer: Do We Have Any Evidence?
- Emetogenic Potential of Antineoplastic Agents
- Combination Abiraterone Acetate, Radium-223 Not Recommended in CRPC With Bone Mets
- Brigatinib Found More Effective for ALK-positive NSCLC Brain Mets Compared With Crizotinib
- Higher Baseline AFP Linked to Greater Benefit With Cabozantinib in Hepatocellular Carcinoma
- Real-World Study Shows High Response Rates to T-VEC in Early Metastatic Melanoma
- A Big BiTE: Tetravalent BiTE Highly Potent in HER2-positive Breast Cancer Models